This document lists various clinical trials and projects spanning multiple medical disciplines. It describes the agent or device, indication being studied, and trial protocol phase for each project. The projects cover areas such as cardiology, oncology, neurology, infectious disease, immunology, endocrinology, gynecology, and more. They involve drugs, biologics, medical devices, and vaccines at various stages of clinical trial and regulatory review.
Background: The coexistence of giant cell tumor (GCT) and metacarpal bone tuberculosis (TB) of the hand has never been described before in the English written literature. We report here a first observation.
Sindrome de Marfan ; Por: Ricardo Mora Moreno MAECO (medico en adiestramiento ecocardiografico), IMSS CMN SS XXI, Hospital de Cardiología, CDMX, 29 de Agosto del 2019
Therapeutic plasma exchange in patients with neurologic diseases: Retrospecti...Apollo Hospitals
Therapeutic plasma exchange (TPE) is commonly used in many neurological disorders where an immune aetiology was known or suspected. We report our experience with TPE performed for neuroimmunologic disorders at four university hospitals.
Background: The coexistence of giant cell tumor (GCT) and metacarpal bone tuberculosis (TB) of the hand has never been described before in the English written literature. We report here a first observation.
Sindrome de Marfan ; Por: Ricardo Mora Moreno MAECO (medico en adiestramiento ecocardiografico), IMSS CMN SS XXI, Hospital de Cardiología, CDMX, 29 de Agosto del 2019
Therapeutic plasma exchange in patients with neurologic diseases: Retrospecti...Apollo Hospitals
Therapeutic plasma exchange (TPE) is commonly used in many neurological disorders where an immune aetiology was known or suspected. We report our experience with TPE performed for neuroimmunologic disorders at four university hospitals.
Functional genomics has led to an improvement of our understanding of CVD and can be translated to clinical utility. Gene-based pre-symptomatic prediction of illness, finer diagnostic sub-classifications and improved risk assessment tools will permit earlier and more targeted intervention. Pharmacogenetics will guide our therapeutic decisions and monitor response to therapy. Personalised medicine requires the integration of clinical information, stable and dynamic genomics and molecular phenotyping.
It is now possible to systematically search the entire human genome for common variants that are associated with a particular phenotype. (HGP, HAP MAP)
Presentación Jornadas Directivas, expertos en formación empresarial, dirigida a profesionales, directivos, mandos intermedios y personal de apoyo. Que deseen completar, actualizar sus conocimientos y mejorar sus competencias.
Functional genomics has led to an improvement of our understanding of CVD and can be translated to clinical utility. Gene-based pre-symptomatic prediction of illness, finer diagnostic sub-classifications and improved risk assessment tools will permit earlier and more targeted intervention. Pharmacogenetics will guide our therapeutic decisions and monitor response to therapy. Personalised medicine requires the integration of clinical information, stable and dynamic genomics and molecular phenotyping.
It is now possible to systematically search the entire human genome for common variants that are associated with a particular phenotype. (HGP, HAP MAP)
Presentación Jornadas Directivas, expertos en formación empresarial, dirigida a profesionales, directivos, mandos intermedios y personal de apoyo. Que deseen completar, actualizar sus conocimientos y mejorar sus competencias.
We are a Portland Oregon based transmedia branded entertainment agency. We work with you to understand your Core brand values / positioning / themes and integrate its messaging strategy into the structural and narrative dimensions of a story.
Austin Journal of Clinical Cardiology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of cardiology and angiology. The aim of the journal is to provide a forum for cardiologists, researchers, physicians, and other health professionals to find most recent advances in the areas of cardiology and cardiovascular diseases.
Austin Journal of Clinical Cardiology accepts original research articles, review articles, case reports, clinical images and rapid communication on all the aspects of cardiology and circulatory system.
Austin Journal of Clinical Cardiology strongly supports the scientific upgradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
Austin Journal of Clinical Cardiology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of cardiology and angiology
24° CORSO RESIDENZIALE DI AGGIORNAMENTO
con il patrocinio dell’Associazione Italiana di Radioterapia Oncologica (AIRO)
Moderna Radioterapia, Nuove Tecnologie e Ipofrazionamento della Dose
17 marzo 2014: Trattamenti ipofrazionati ed ipofrazionati-accelerati: nuove possibilità di prevenzione e trattamento della tossicità acuta e tardiva
Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: effica...Enrique Moreno Gonzalez
Recombinant human endostatin (rh-endostatin) is a novel antiangiogenesis drug developed in
China. Previous experiments have shown that rh-endostatin can inhibit the proliferation and
migration of endothelial cells and some types of tumor cells. In this study, we evaluated the
efficacy and safety profiles of combination therapy of rh-endostatin and neoadjuvant
chemotherapy for breast cancer patients in a prospective, randomized, controlled, phase II
trial.
Roy H. Decker, MD, PhD, and Sarah B. Goldberg, MD, MPH, prepared useful practice aids pertaining to lung cancer for this CME activity titled "The Era of Immunotherapy in Stage III NSCLC: Exploring the Evidence and Practicalities of Integrating Checkpoint Inhibition Into the Multimodal Treatment Arsenal." For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2PU3iaZ. CME credit will be available until December 6, 2019.
Edward B. Garon, MD, MS, Jamie E. Chaft, MD, and Matthew D. Hellmann, MD, prepared useful Practice Aids pertaining to lung cancer management for this CME/MOC/CE activity titled "Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice." For the full presentation, monograph, complete CME/MOC/CE information, and to apply for credit, please visit us at http://bit.ly/2ATq0qp. CME/MOC/CE credit will be available until November 21, 2019.
1. Kenneth Wu, LLC Page 1 of 3
Contracting and Consulting Projects
Discipline Agent/Device Indication Protocol Phase
Heart Failure
Pacemakers and
Defibrillators
Bradycardia and Cardiac
Arrhythmia
Registration and Post-marketing
Global Clinical Trials
IDE/PMA
Neurologic Combination drug Dementia Bioequivalence studies Phase I
Oncology
Biologic Breast cancer
Dose Ranging and Maximum
Tolerated Dose (MTD)
Phase IIa
Biologic Ovarian Phase IIa
Monoclonal Antibody Lung Phase IIb
Congestive Heart
Failure
Natrecor
(Brain Naturietic
Peptide)
Congestive Heart Failure
(Class IV)
Expand Label to Outpatient
Administration
Phase IIIb
Intravascular
Intervention
Local Delivery of
Beta Radiation
Coronary restenosis
Reduction in coronary restenosis in
stented vessels
Class III PMA
Coronary Stent Coronary occlusions
Coronary stenting with new bare
metal stent design
Class III PMA
Cardiac Surgery
Transmyocardial
Revascularization
(TMR)
Adjunct to Coronary
Bypass Surgery
Percutaneous Approach to
Myocardium Revascularization
(PMR)
Class III PMA
Minimally Invasive
Surgery
Implantable Device
Severe and Morbidly
Obese
Open, Non-randomized, Single
Arm Study
Class III
PMA
Urology Protoporphyrin Prostate Cancer Drug Uptake Study I
Ophthalmology Protoporphyrin
Age Related Macular
Degeneration
Dose Ranging Study II
Oncology Protoporphyrin
Cutaneous Breast
Cancer
Safety and Efficacy Study III
Radiation Oncology
Gadolinium
Texaphyrin
Metastatic Cancer to the
Brain
Safety Study and Dose Ranging
Study
I and II
Radiology
Gadolite; Positive
MRI Contrast Agent
Placebo Control Placebo Comparison Study II
Radiology
Gadolite; Positive
MRI Contrast Agent
Pelvic Pain
Efficacy of Positive MRI Contrast
Agent
III
2. Kenneth Wu, LLC Page 2 of 3
Contracting and Consulting Projects
Discipline Agent/Device Indication Protocol Phase
Pharmacokinetic
Pharmacology
Angiotensin-Renin II
Receptor Antagonist
Patients with Stable
Hypertension
Dose Ranging Study to Determine
the Optimal Dose
II
Interventional
Radiology
Thrombolytic
Patients with Peripheral
Vascular Occlusions
Efficacy and Safety of Thrombolytic
in Comparison to Surgical
Intervention
III
Emergency Medicine
Biological
Thrombolytic
Patients with Acute
Myocardial Infarcts
Efficacy and Safety of Thrombolytic
for Acute Myocardial Infarct
III
Internal Medicine;
Immunology
Monoclonal Antibody
Patients with Arthritic
Joints
Safety and Efficacy of Monoclonal
Antibody Treatment for
Symptomatic Arthritic Patients
III
Infectious Disease;
Sexually Transmitted
Disease (STD)
Quinolone Antibiotic
Women Tested Positive
with N. Gonorrhea
Efficacy and Safety of Quinalone
in Women with Test Positive for N.
Gonorrhea
III
Allergy and Asthma;
Immunology
Quinolone Antibiotic Chronic Bronchitis
Efficacy and Safety of Drug in
Patients with Bronchitis in
Comparison to Approved Controls
III
Internal Medicine;
Geriatrics
Anti-inflammatory;
Nonsteriodal
Arthritis Symptoms Safety and Efficacy of NSAID III
Psychiatric Antidepressant
Manic Depressive
Patients
Safety and Efficacy of
Antidepressant
III
Pediatrics Vaccine
Whooping Cough
Immunization for
Toddlers
Immunization Study III
Internal Medicine;
Endocrinology
Antiglycolsylation
Agent
Symptomatic and
Asymptomatic Insulin
Dependent Diabetics
Safety and Efficacy of Antidiabetic
Effects of Antiglycolsyation Agent
III
Gynecology and
Obstetrics
Low Molecular
Weight Estrogen
Hormone Replacement
for Postmenopausal
Women
Safety and Efficacy of Low Dose
Estrogen Replacement Therapy
III
3. Kenneth Wu, LLC Page 3 of 3
Contracting and Consulting Projects
Discipline Agent/Device Indication Protocol Phase
Gynecology and
Obstetrics
Multiphasic
Estrogen/Progestero
ne Birth Control Pill
Birth Control
Comparative Study Against
Approved Drug for Comparison of
Effectiveness
III
Gynecology and
Obstetrics
Combination
Estrogen and
Progesterone Pill
Birth Control
Comparative Study Against
Approved Drug for Comparison of
Effectiveness
III
Internal Medicine
Antiplatelet
Aggregating Factor
(PAF)
Post Acute Stroke
Patients
Efficacy and Safety of Anti- PAF III
Internal Medicine
Calcium Channel
Blocker
Chronic and Stable
Hypertensives
Efficacy and Safety of Third
Generation Calcium Channel
Blocker
II
Internal Medicine
Calcium Channel
Blocker
Chronic and Stable
Hypertensives
Efficacy and Safety of Third
Generation Calcium Channel
Blocker
III